Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure

Figure 3. For the base-case point estimate ( ), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year ( ).
Figure 3. For the base-case point estimate ( ), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year ( ). Distribution of incremental costs versus incremental effects for cardiac resynchronization therapy versus medical therapy.white XQALY

This Article

  1. Published online before print July 12, 2004, Ann Intern Med September 7, 2004 vol. 141 no. 5 343-351
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues